- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 682.17M sh |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $750M |
| Short Term Debt | Q1 2025 · Mar 31, 2024 | $2.15B |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $63M |
| Short Term Investments | Q1 2025 · Mar 31, 2024 | $153M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.11B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $1.51B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $23.79B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $24.77B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $10.39B |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $11.33B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $15.1B |
| Current Assets | Q1 2025 · Mar 31, 2024 | $17.16B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $40.83B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $43.63B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 702.8M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $252M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $112M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.61B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.60 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.60 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $736M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $332M |
| Net Income | Q1 2025 · Mar 31, 2024 | $419M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.55B |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.49B |